Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine

The rates of accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate (ddATP) have been examined after incubation with the anti-human immunodeficiency virus (HIV) agents 2',3'-dideoxyinosine (ddIno) and 2',3'-dideoxyadenosine (ddAdo) in human T-cell systems...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and disposition Vol. 21; no. 2; p. 369
Main Authors Ahluwalia, G, Cooney, D A, Hartman, N R, Mitsuya, H, Yarchoan, R, Fridland, A, Broder, S, Johns, D G
Format Journal Article
LanguageEnglish
Published United States 01.03.1993
Subjects
Antiviral Agents - pharmacology
Cells, Cultured
Deoxyadenine Nucleotides - pharmacokinetics
Didanosine - pharmacology
Dideoxyadenosine - pharmacology
Dideoxynucleotides
Half-Life
HIV - drug effects
Humans
IMP Dehydrogenase - metabolism
Ribavirin - pharmacology
T-Lymphocytes - drug effects
T-Lymphocytes - metabolism
Online AccessGet more information

Cover

More Information
Summary:The rates of accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate (ddATP) have been examined after incubation with the anti-human immunodeficiency virus (HIV) agents 2',3'-dideoxyinosine (ddIno) and 2',3'-dideoxyadenosine (ddAdo) in human T-cell systems frequently used for assay of anti-HIV agents (MOLT-4 and CEM). Formation of ddATP from ddIno or ddAdo was rapid and concentration-dependent, with no saturation of phosphorylation being observed up to extremely high levels (1 mM) of drug. Rates of removal of ddATP from MOLT-4 cells were slow (t1/2 = 25-40 hr) and appeared to be monophasic. These unusually long half-times for ddATP utilization are not a general property of purine dideoxypurine nucleosides: when the corresponding guanine analog (2',3'-dideoxyguanosine) was examined under the same conditions, the t1/2 of ddGTP removal was only 3-5 hr. Similar results were observed with the human T-cell line CCRF-CEM. Coadministration with ddIno of inosine monophosphate dehydrogenase inhibitors, such as ribavirin and tiazofurin, yielded higher levels of ddATP in MOLT-4 and CEM cells, but did not influence the slow removal of ddATP from T-cells. The long half-time for disappearance of ddATP from cells may permit the maintenance of pharmacologically effective levels of ddATP within cells with relatively infrequent administration of the parent drug (ddIno or ddAdo).
ISSN:0090-9556